Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 11, 2021 Filed Oct 13, 2021 21:04 UTC |
TETRAULT LYNN A.Director
|
GrantStock Option (Right to Buy) · Derivative | 972 | $0.00 Strike: $41.76 | $0.00 |
DisclosureSEC source: 0001077183-21-000227 · wf-form4_163415907002611.xml · derivative · entry 7 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 972 Underlying: Common Stock · 972 shares Expires 2028-10-11 Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 21:04 UTC |
TETRAULT LYNN A.Director
|
GrantCommon Stock | 838 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000227 · wf-form4_163415907002611.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,777 Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:42 UTC |
Gilbert Halley EChief Legal Officer
|
GrantCommon Stock · Derivative | 63,331 | $0.00 Strike: $42.21 | $0.00 |
DisclosureSEC source: 0001077183-21-000214 · wf-form4_162940935536512.xml · derivative · entry 2 Gilbert Halley E · CIK 0001601360 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,331 Underlying: Common Stock · 63,331 shares Expires 2028-08-17 F1 · derivative.exercise_date: On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:42 UTC |
Gilbert Halley EChief Legal Officer
|
GrantCommon Stock | 59,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000214 · wf-form4_162940935536512.xml · nonDerivative · entry 1 Gilbert Halley E · CIK 0001601360 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,228 Read SEC document |
| August 01, 2021 Filed Aug 13, 2021 21:12 UTC |
VAN OORT DOUGLAS MDirector
|
Tax withholdingCommon Stock | 5,919 | $46.10 | $272,865.90 |
DisclosureSEC source: 0001077183-21-000210 · wf-form4_162888913972963.xml · nonDerivative · entry 2 VAN OORT DOUGLAS M · CIK 0001518733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,468,797 F1 · shares: Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the August 1, 2021 vesting of restricted stock. Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 23:02 UTC |
CARDOZA GEORGEPresident & COO, Lab Ops
|
GrantStock Option (Right to Buy) · Derivative | 40,502 | $43.95 Strike: $43.95 | $1,780,062.90 |
DisclosureSEC source: 0001077183-21-000187 · wf-form4_162569890401981.xml · derivative · entry 8 CARDOZA GEORGE · CIK 0001518734 · President & COO, Lab Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,502 Underlying: Common Stock · 40,502 shares Expires 2028-07-05 F6 · derivative.exercise_date: On July 5, 2021, Mr. Cardoza was granted 40,502 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 23:02 UTC |
CARDOZA GEORGEPresident & COO, Lab Ops
|
GrantCommon Stock | 7,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000187 · wf-form4_162569890401981.xml · nonDerivative · entry 2 CARDOZA GEORGE · CIK 0001518734 · President & COO, Lab Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,356 Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 23:01 UTC |
Wallar Gina MPresident, Pharma Services
|
GrantStock Option (Right to Buy) · Derivative | 10,126 | $43.95 Strike: $43.95 | $445,037.70 |
DisclosureSEC source: 0001077183-21-000186 · wf-form4_162569888733988.xml · derivative · entry 7 Wallar Gina M · CIK 0001869819 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,126 Underlying: Common Stock · 10,126 shares Expires 2028-07-05 F6 · derivative.exercise_date: On July 5, 2021, Ms. Wallar was granted 10,126 stock options. The options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 23:01 UTC |
Wallar Gina MPresident, Pharma Services
|
GrantCommon Stock | 1,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000186 · wf-form4_162569888733988.xml · nonDerivative · entry 1 Wallar Gina M · CIK 0001869819 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,013 Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 23:01 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
GrantStock Option (Right to Buy) · Derivative | 4,050 | $43.95 Strike: $43.95 | $177,997.50 |
DisclosureSEC source: 0001077183-21-000185 · wf-form4_162569887133383.xml · derivative · entry 7 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,050 Underlying: Common Stock · 4,050 shares Expires 2028-07-05 F6 · derivative.exercise_date: On July 5, 2021, Ms. Balliet was granted 4,050 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 23:01 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
GrantCommon Stock | 758 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000185 · wf-form4_162569887133383.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,215 Read SEC document |
| June 22, 2021 Filed Jul 15, 2021 20:58 UTC |
Dieter Cynthia JChief Accounting Officer
|
Tax withholdingCommon Stock | 56 | $43.99 | $2,463.44 |
DisclosureSEC source: 0001077183-21-000195 · wf-form4_162638266483036.xml · nonDerivative · entry 1 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the June 22, 2021 vesting of restricted stock. Read SEC document |
| June 18, 2021 Filed Jul 15, 2021 20:58 UTC |
Morris ClivePresident of Inivata
|
GrantStock Option (Right to Buy) · Derivative | 53,857 | $43.58 Strike: $43.58 | $2,347,088.06 |
DisclosureSEC source: 0001077183-21-000196 · wf-form4_162638269914340.xml · derivative · entry 2 Morris Clive · CIK 0001869893 · President of Inivata 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,857 Underlying: Common Stock · 53,857 shares Expires 2028-06-18 F1 · derivative.exercise_date: On June 18, 2021, Mr. Morris was granted 53,857 stock options. The options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| June 18, 2021 Filed Jul 15, 2021 20:58 UTC |
Morris ClivePresident of Inivata
|
GrantCommon Stock | 10,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000196 · wf-form4_162638269914340.xml · nonDerivative · entry 1 Morris Clive · CIK 0001869893 · President of Inivata 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,708 Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 21:07 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,389 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001077183-21-000168 · wf-form4_162370485942931.xml · derivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,389 shares Expires 2021-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On July 28, 2016, Lynn Tetrault was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 21:07 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionCommon Stock | 1,389 | $9.11 | $12,653.79 |
DisclosureSEC source: 0001077183-21-000168 · wf-form4_162370485942931.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:01 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · derivative · entry 9 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:01 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,269 | $0.00 Strike: $22.52 | $0.00 |
DisclosureSEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · derivative · entry 8 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,269 shares Expires 2026-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:01 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · derivative · entry 7 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:01 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · derivative · entry 6 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 25, 2017, Mr. Crowther was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:01 UTC |
CROWTHER BRUCE KDirector
|
SaleCommon Stock | 20,734 | $41.46 | $859,631.64 |
DisclosureSEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 5 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,564 Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:01 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionCommon Stock | 3,448 | $28.54 | $98,405.92 |
DisclosureSEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 4 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:01 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionCommon Stock | 4,269 | $22.52 | $96,137.88 |
DisclosureSEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 3 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:01 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionCommon Stock | 3,017 | $11.60 | $34,997.20 |
DisclosureSEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 2 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:01 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionCommon Stock | 10,000 | $7.27 | $72,700.00 |
DisclosureSEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 23:56 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
SaleCommon Stock | 31,107 | $40.11 | $1,247,701.77 |
DisclosureSEC source: 0001077183-21-000155 · wf-form4_162285098363912.xml · nonDerivative · entry 3 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,772 Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 00:00 UTC |
HANNAH ALISON L.Director
|
GrantStock Option (Right to Buy) · Derivative | 3,714 | $0.00 Strike: $40.90 | $0.00 |
DisclosureSEC source: 0001077183-21-000162 · wf-form4_162285118004344.xml · derivative · entry 5 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 Underlying: Common Stock · 3,714 shares Expires 2028-06-02 Read SEC document |
| June 02, 2021 Filed Jun 5, 2021 00:00 UTC |
HANNAH ALISON L.Director
|
GrantCommon Stock | 3,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000162 · wf-form4_162285118004344.xml · nonDerivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,877 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:59 UTC |
Kelly Michael AaronDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,714 | $0.00 Strike: $40.90 | $0.00 |
DisclosureSEC source: 0001077183-21-000161 · wf-form4_162285111388362.xml · derivative · entry 3 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 Underlying: Common Stock · 3,714 shares Expires 2028-06-02 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:59 UTC |
Kelly Michael AaronDirector
|
GrantCommon Stock | 3,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000161 · wf-form4_162285111388362.xml · nonDerivative · entry 1 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,863 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:58 UTC |
Johnson Kevin CDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,714 | $0.00 Strike: $40.90 | $0.00 |
DisclosureSEC source: 0001077183-21-000160 · wf-form4_162285108497293.xml · derivative · entry 5 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 Underlying: Common Stock · 3,714 shares Expires 2028-06-02 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:58 UTC |
Johnson Kevin CDirector
|
GrantCommon Stock | 3,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000160 · wf-form4_162285108497293.xml · nonDerivative · entry 1 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,064 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:58 UTC |
Stahler Rachel ADirector
|
GrantStock Option (Right to Buy) · Derivative | 3,714 | $0.00 Strike: $40.90 | $0.00 |
DisclosureSEC source: 0001077183-21-000159 · wf-form4_162285106307216.xml · derivative · entry 3 Stahler Rachel A · CIK 0001679854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 Underlying: Common Stock · 3,714 shares Expires 2028-06-02 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:58 UTC |
Stahler Rachel ADirector
|
GrantCommon Stock | 3,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000159 · wf-form4_162285106307216.xml · nonDerivative · entry 1 Stahler Rachel A · CIK 0001679854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,779 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:57 UTC |
TETRAULT LYNN A.Director
|
GrantStock Option (Right to Buy) · Derivative | 3,714 | $0.00 Strike: $40.90 | $0.00 |
DisclosureSEC source: 0001077183-21-000158 · wf-form4_162285104607570.xml · derivative · entry 7 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 Underlying: Common Stock · 3,714 shares Expires 2028-06-02 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:57 UTC |
TETRAULT LYNN A.Director
|
GrantCommon Stock | 3,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000158 · wf-form4_162285104607570.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,550 F1 · balance_after: Since the date of the reporting person's last report, Ms. Tetrault transferred 13,882 shares of NEO common stock to a former indirect beneficial owner pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the former indirect beneficial owner. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:57 UTC |
CROWTHER BRUCE KDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,714 | $0.00 Strike: $40.90 | $0.00 |
DisclosureSEC source: 0001077183-21-000157 · wf-form4_162285102497183.xml · derivative · entry 6 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 Underlying: Common Stock · 3,714 shares Expires 2028-06-02 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:57 UTC |
CROWTHER BRUCE KDirector
|
GrantCommon Stock | 3,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000157 · wf-form4_162285102497183.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,564 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:57 UTC |
KANOVSKY STEPHEN MDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,714 | $0.00 Strike: $40.90 | $0.00 |
DisclosureSEC source: 0001077183-21-000156 · wf-form4_162285100556937.xml · derivative · entry 4 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 Underlying: Common Stock · 3,714 shares Expires 2028-06-02 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:57 UTC |
KANOVSKY STEPHEN MDirector
|
GrantCommon Stock | 3,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000156 · wf-form4_162285100556937.xml · nonDerivative · entry 1 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,198 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 23:56 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
SaleCommon Stock | 169,230 | $40.39 | $6,835,199.70 |
DisclosureSEC source: 0001077183-21-000155 · wf-form4_162285098363912.xml · nonDerivative · entry 2 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,879 Read SEC document |
| May 25, 2021 Filed May 27, 2021 22:23 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,067 | $0.00 Strike: $28.33 | $0.00 |
DisclosureSEC source: 0001077183-21-000134 · wf-form4_162215415171071.xml · derivative · entry 8 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,204 Underlying: Common Stock · 14,067 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| May 25, 2021 Filed May 27, 2021 22:23 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,724 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001077183-21-000134 · wf-form4_162215415171071.xml · derivative · entry 7 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,449 Underlying: Common Stock · 16,724 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| May 25, 2021 Filed May 27, 2021 22:23 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 96,167 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-21-000134 · wf-form4_162215415171071.xml · derivative · entry 6 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,167 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| May 25, 2021 Filed May 27, 2021 22:23 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
SaleCommon Stock | 130,604 | $39.31 | $5,134,043.24 |
DisclosureSEC source: 0001077183-21-000134 · wf-form4_162215415171071.xml · nonDerivative · entry 4 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,101 Read SEC document |
| May 25, 2021 Filed May 27, 2021 22:23 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 14,067 | $28.33 | $398,518.11 |
DisclosureSEC source: 0001077183-21-000134 · wf-form4_162215415171071.xml · nonDerivative · entry 3 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 27, 2021 22:23 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 16,724 | $19.60 | $327,790.40 |
DisclosureSEC source: 0001077183-21-000134 · wf-form4_162215415171071.xml · nonDerivative · entry 2 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 27, 2021 22:23 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 96,167 | $8.03 | $772,221.01 |
DisclosureSEC source: 0001077183-21-000134 · wf-form4_162215415171071.xml · nonDerivative · entry 1 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 21:48 UTC |
Weiss Lawrence MartinChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,378 | $0.00 Strike: $28.33 | $0.00 |
DisclosureSEC source: 0001077183-21-000113 · wf-form4_161947371579723.xml · derivative · entry 6 Weiss Lawrence Martin · CIK 0001761625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,136 Underlying: Common Stock · 9,378 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 21:48 UTC |
Weiss Lawrence MartinChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,005 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001077183-21-000113 · wf-form4_161947371579723.xml · derivative · entry 5 Weiss Lawrence Martin · CIK 0001761625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,012 Underlying: Common Stock · 9,005 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.